High Mark Wealth Management LLC Crinetics Pharmaceuticals, Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 19,995 shares of CRNX stock, worth $670,632. This represents 0.59% of its overall portfolio holdings.
Number of Shares
19,995
Previous 19,995
-0.0%
Holding current value
$670,632
Previous $1.02 Million
0.1%
% of portfolio
0.59%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding CRNX
# of Institutions
256Shares Held
82.5MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$305 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$209 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$206 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$182 Million0.03% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.29MShares$144 Million10.24% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.8B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...